Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Alejandro Perez-Fidalgo
Correction: ER+ Breast Cancers Resistant to Prolonged Neoadjuvant Letrozole Exhibit an E2F4 Transcriptional Program Sensitive to CDK4/6 Inhibitors
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Treating ER+ Breast Cancer With CDK4/6 Inhibitors
Cancer Discovery
Oncology
Loss of FAT1 Drives Resistance to CDK4/6 Inhibitors in Breast Cancer
Cancer Discovery
Oncology
CDK4/6 Inhibitors: Promising Opportunities Beyond Breast Cancer
Cancer Discovery
Oncology
CDK4/6 Inhibitors resTORe Therapeutic Sensitivity in HER2 + Breast Cancer
Cancer Cell
Cancer Research
Oncology
Cell Biology
Inhibitors Targeting CDK4/6, PARP and PI3K in Breast Cancer: A Review
Therapeutic Advances in Medical Oncology
Oncology
Correction: CDK4/6 Inhibitors in the Treatment of Patients With Breast Cancer: Summary of a Multidisciplinary Round-Table Discussion
ESMO Open
Cancer Research
Oncology
Stromal Senescence by Prolonged CDK4/6 Inhibition Potentiates Tumor Growth
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
Cdk4/6 Inhibitors and Overall Survival: Power of First-Line Trials in Metastatic Breast Cancer
npj Breast Cancer
Oncology
Radiology
Nuclear Medicine
Pharmacology
Imaging
Distinct P53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers
Clinical Cancer Research
Cancer Research
Oncology